Takeda Pharmaceutical (TAK) Fair Value & DCF
Score
TAK fair value $3,621.70. Price $21.41. Price is 99% below fair value.
Worked example
Cash-flow value. Starting free cash flow is $140.06 a share. Years 1 to 5 grow at 4.58%. Years 6 to 10 fade that rate in a straight line to 3% terminal growth. The discount rate is 8.70% (beta 0.80). It is beta-adjusted and capped at 12%. The cash-flow value is $1,424.61 a share.
Earnings value. Next-twelve-months earnings per share of $193.96 times 30.00 is $5,818.79. The peer group is Healthcare, 79 companies worth at least $10 billion. Peer median 29.0. Own 10-year median 35.8. The multiple used is the average of the two, kept between 8 and 30, which is 30.00.
Fair value is the average of the two, $3,621.70. The price is $21.41, which is 99.4% below fair value.